Albuminuria is a risk factor for cognitive decline in relatively young adults with diabetes and normal renal function, a new study suggests. In the study, diabetic patients with persistent ...

Albuminuria is a widely used biomarker for CKD prognosis and response to therapeutic interventions; however, there is large intra-individual day-to-day variability, up to 40%.

Albuminuria is an independent predictor for microvascular and macrovascular complications, and hence screening people with prediabetes for albuminuria may help to identify those with the highest ...

The identification of mutations in genes expressed by podocytes as the genetic cause of albuminuria in both familial and sporadic kidney disease has spurred research into podocyte pathobiology and ...

Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney ...

"BioCity’s SC0062 gains NMPA breakthrough therapy designation" was originally created and published by Pharmaceutical ...

BOSTON — Finerenone reduces CV and renal events in patients with type 2 diabetes and chronic kidney disease, and albuminuria is a good screening tool to identify candidates, according to a speaker.

Early albuminuria reduction with finerenone (Kerendia) drove protection against chronic kidney disease (CKD) progression in people with type 2 diabetes, according to a post-hoc mediation analysis.

An SGLT2 inhibitor combined with a nonsteroidal mineralocorticoid receptor antagonist quickly cut urinary albumin-to-creatinine ratio (UACR) in patients with albuminuria and both chronic kidney ...

Albuminuria testing occurred in 17.5% of patients, Chi D. Chu, MD, MAS, of University of California, San Francisco, and colleagues reported. Among those tested, 34.3% had albuminuria.

Microcalcification activity was positively associated with the extent of albuminuria, and a trend remained after adjustment. Average myocardial flow reserve ...